Loading company…
Sunovion Pharmaceuticals Europe develops and commercializes treatments for psychiatric and neurological conditions.
Based in London and established in 2010, Sunovion Pharmaceuticals Europe is the UK subsidiary of Sunovion Pharmaceuticals. It commercialized lurasidone in the UK for schizophrenia treatment beginning in 2014. The company focuses on therapies for conditions including schizophrenia, bipolar depression, and partial-onset seizures associated with epilepsy.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in